The Carmat artificial heart
February 10, 2021
FDA OKs Use New Version of Carmat Artificial Heart in U.S. Early Feasibility Study
February 10, 2021 - The U.S. Food and Drug Administration (FDA) has granted artificial heart developer Carmat approval…
Read More
InspireMD's MicroNet embolic protection mesh on stents is designed to prevent emboli during carotid stenting.
February 09, 2021
CGuard Carotid Embolic Protection Device Trial Will be Led by Chris Metzger
February 9, 2021 — InspireMD Inc., developer of the CGuard Embolic Prevention System (EPS) for the prevention of stroke…
Read More
The EndoWays disposable robotic system for cath lab procedural navigation. EndoWays, developer of a disposable robotic system for the cath lab, announced the completion of an acquisition of a majority of its shares by Ascendum
February 09, 2021
First Disposable Cath Lab Robot Technology Acquired by Ascendum
February 9, 2021 — EndoWays, developer of a disposable robotic system for the cath lab, announced the completion of an…
Read More
To help monitor the health of ACC 2021 in-person attendees for signs of COVID infection, the meeting will use BioIntelliSense's wearable BioButton continuous wireless temperature and vital signs monitoring. The wearable monitor is the size of a coin and is disposable.
By Dave Fornell, Editor
February 09, 2021
ACC Plans for In-Person 2021 Meeting in May With Wearable Biomonitors
UPDATE Feb 22, 2021 — ACC Abandons In-person Meeting and Goes Entirely Virtual for 2021 Due to COVID February 9, 2021…
Read More
Teleflex Acquires Hemostatic Products Vendor Z-Medica
February 08, 2021
Teleflex Acquires Hemostatic Products Vendor Z-Medica
February 8, 2021 — Teleflex Inc. said it recently completed its acquisition of Z-Medica LLC, an industry-leading…
Read More
Patients with bicuspid, or two-leaflet, aortic valves who undergo transcatheter aortic valve replacement (TAVR) procedures had a high rate of success and low risk of death or disabling stroke at 30 days, according to new data presented at the American College of Cardiology (ACC) 2020 Scientific Session.
February 04, 2021
Bicuspid Aortic TAVR May Create Huge Market For Transcatheter Valves
February 4, 2021 — Transcatheter aortic valve replacement (TAVR) has historically only been used with caution in the…
Read More
An interventional radiologist consults with a patient in an out patient cath lab at a Modern Vascular clinic. The company is building several out patient clinics to capture a share of the interventional market for peripheral artery disease (PAD) catheter-based therapies. 
February 03, 2021
Modern Vascular Opens New Outpatient Cath Lab to Treat Peripheral Artery Disease
February 3, 2021 — Modern Vascular is a medical group that has 13 outpatient cath lab clinics to treat peripheral…
Read More
Figure 1: Picture of the Emblem S-ICD Subcutaneous Electrode with an arrow showing where separation usually happens (distal to the proximal sense ring).
By Dave Fornell, Editor
February 02, 2021
Boston Scientific Recalls Emblem S-ICD After 26 Serious Injuries and One Death
February 2, 2020 — The U.S. Food and Drug Administration (FDA) has identified a recent recall of the Boston Scientific…
Read More
The Optimize EP CaRM software integrates data from several EP devices a patients may use and aggregate it into one location.
February 02, 2021
Patient Data From Several Cardiac Devices Streamlined Into One Platform With New Cloud-based Software
February 2, 2021 – Optimize EP, a digital health company focused on transforming cardiac care by improving the current…
Read More
There has been an increasing trend in cardiology to use longer term remote monitoring wearable ECG tracking devices. This is an example of of the Cardiac Insight Cardea Solo adhesive patch device.
February 02, 2021
Cardiac Insight Speaks Out Against Medicare Decision to Slash Reimbursement Rates and Limit Access to New ECG Technologies 
February 2, 2021 — Cardiac Insight, Inc. a healthcare company specializing in wearable cardiac sensors and automated…
Read More
A study of more than 100 million Americans in 3,123 counties found a correlation between cardiac death and their level of income. Getty Images Health disparities in cardiovascular disease.
February 02, 2021
Link Shown Between Economic Disparities and Cardiovascular Death in Middle-Aged Adults
February 2, 2021 — A new study has found in the U.S. shows higher economic prosperity was associated with a small…
Read More
By Dave Fornell, Editor
February 01, 2021
Most Popular Cardiology Technology Content in January 2021 
February 1, 2021 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC)…
Read More
Medtronic's DiamondTemp Ablation (DTA) system is FDA cleared to treat patients with recurrent, symptomatic paroxysmal atrial fibrillation (AF) and who have been unresponsive to drug therapy. The DiamondTemp system is the first FDA-approved, temperature-controlled, irrigated radiofrequency (RF) ablation system with diamonds currently available to deliver ablations.
January 29, 2021
FDA Clears Medtronic DiamondTemp Ablation System to Treat Atrial Fibrillation
January 29, 2021 — The U.S. Food and Drug Administration (FDA) has cleared Medtronic's DiamondTemp Ablation (DTA)…
Read More
January 29, 2021
North American Medical Devices Deals Drops in late 2020
January 29, 2020 — North America’s medical devices industry saw a drop of 17.3% in overall deal activity during the…
Read More
Patients with atrial fibrillation are at far greater risk of a catastrophic COVID outcomes, so steps should be taken to reduce AFib risks in addition to precautions against COVID like making, hand washing and social distancing. Images include an electromap from an AF ablation procedure and a COVID-19 from the CDC. 
By John D. Day, M.D., T. Jared Bunch, M.D., and Matthew D. LaPlante
January 27, 2021
Addressing Atrial Fibrillation in the World of COVID-19
In our most challenging and distressing days, it is nice to think about a post-COVID-19 world.  But while this pandemic…
Read More
The Philips AAA Model integrates software and Philips 3-D ultrasound technologies into a single solution to automatically segment and quantify the size of the aneurysm sac for surveillance of known native and post-EVAR treated AAAs.
January 27, 2021
Philips 3-D Ultrasound Offers New Surveillance Method for Abdominal Aortic Aneurysms
January 27, 2021 — Philips Healthcare has introduced the Philips Abdominal Aortic Aneurysm (AAA) Model, providing…
Read More
Heavily calcified coronary arteries seen on a CT scan of the heart. Research at the New York Institute of Technology will create blood flow modeling to show the impact of calcium in arteries as part of a project to develop treatments to remove calcium.
January 27, 2021
Vascular Decalcification as Heart Disease Treatment Examined in $1.8 Million NIH Grant
January 27, 2021 — A New York Institute of Technology research team has secured a five-year $1.8 million grant from the…
Read More
The Occlutech implantable Atrial Flow Regulator (AFR) maintains an interatrial shunt with a predetermined diameter allowing for controlled blood flow from the left to the right atrium enabling the left atrium to decompress and lower left atrial pressure. This reduced left atrial pressure reduces heart failure symptoms and improves exercise tolerance.
January 27, 2021
Occlutech's Atrial Flow Regulator for Heart Failure Receives FDA Breakthrough Device Designation
January, 27, 2021 — The U.S. Food and Drug Administration (FDA) has granted Occlutech a Breakthrough Device designation…
Read More
The Pedra Blood Perfusion Index tracks real-time changes in foot tissue perfusion attendant with balloon inflation and deflation during an angioplasty procedure.
January 26, 2021
Pedra Tissue Perfusion System Receives FDA Breakthrough Device Designation
January 26, 2021 — Pedra Technology, a privately held company, announced today that the U.S. Food and Drug…
Read More
FDA Clears Boston Scientific Synergy Megatron Drug-eluting Stent for Proximal, Fibrotic and Calcified Lesions
January 26, 2021
FDA Clears Boston Scientific Synergy Megatron Drug-eluting Stent for Proximal, Fibrotic and Calcified Lesions
January 26, 2021 — The U.S. Food and Drug Administration (FDA) has cleared Boston Scientific's Synergy Megatron Drug-…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now